Moreover, the distribution of CD4+ T cells and CD8+ T cells in tumor tissues was also checked to assess the immune response after combinatorial OncoAd and PD‐1 mAb therapy (Figure 5G,H). This evidence concerns the gene CD4 and neoplasm.